CD44 and cancer: Quantitative polymerase chain reaction (qPCR) revealed that the transcription level of MIR31HG, as well as three stem cell specific markers (CD133, CD34, and CD44) were significantly higher in cancer stem cell types than in parental cells (Fig. 1G).